PLIN2 and nasopharyngeal carcinoma: MARCH6 targets several other lipid-related substrates, including perilipin-2 (PLIN2), Niemann-Pick disease (NPC) intracellular cholesterol transporter 1 (NPC1), and the bile salt export pump (BSEP).